Elderly US patients not receiving chemo for AML

Tuesday 31 January 2012

A recent analysis suggests that over half of elderly patients with acute myeloid leukaemia (AML) are not receiving any chemotherapy. The research found that median survival as well as chemotherapy use declined with advancing age.


>> http://www.oncologystat.com/news/Many_Elderly_AML_Patients_Not_Receiving_Chemotherapy_US.html


Further information

Recent stories

Medical paternalism: who knows best?
>> Find out more

Guidelines for individuals: reduce cancer risk
>> Find out more

Patient focus: hysterectomy surgery protocols
>> Find out more

Elderly US patients not receiving chemo for AML
>> Find out more

Hospital reimbursements linked to patient satisfaction in US
>> Find out more

Do half of older cancer patients have unrecognised medical problems?
>> Find out more

Your rights to cross-border healthcare
>> Find out more

Advanced practice nursing comparable to physician care
>> Find out more

EU travellers reminded to carry EHIC card
>> Find out more

Tobacco avoidance is not the only way to lower cancer risk
>> Find out more

New drug approved by FDA for metastatic prostate cancer
>> Find out more

UK charity to set up trials network for blood cancer patients
>> Find out more

One-to-one care improves experience of cancer patients.
>> Find out more

Strength and fitness programme aids cancer survivors
>> Find out more

US Diabetes guidelines emphasise individualised care plans
>> Find out more

Could banking stem cells save Fukushima workers?
>> Find out more

Mistakes made with 1 in 3 US hospital patients
>> Find out more

Shortage worsens of leukaemia drug
>> Find out more

New online store for cancer patients
>> Find out more

European Oncology Nursing Society
Avenue E. Mounier 83
B-1200 Brussels
Belgium
Tel: +32 (0)2 779 9923
Fax: +32 (0)2 779 9937
eons.secretariat@cancernurse.eu